Duffy M J, O'Grady P
Eur J Cancer Clin Oncol. 1984 May;20(5):577-82. doi: 10.1016/0277-5379(84)90001-4.
Plasminogen activator is a protease which catalyses the conversion of the inactive plasminogen to the active plasmin. Most transformed cell lines and solid tumors produce elevated levels of plasminogen activator compared with nontransformed counterparts. This increased synthesis of plasminogen activator may play a role in tumorigenesis, cancer invasion and metastasis. Measurement of plasminogen activator in tumor extracts and body fluids may provide diagnostic and prognostic information. Finally, since plasminogen activator is an estradiol-inducible enzyme, its measurement in breast carcinomas might be a marker for a functional estrogen receptor.
纤溶酶原激活剂是一种蛋白酶,它催化无活性的纤溶酶原转化为活性纤溶酶。与未转化的对应物相比,大多数转化细胞系和实体瘤产生的纤溶酶原激活剂水平升高。纤溶酶原激活剂合成的增加可能在肿瘤发生、癌症侵袭和转移中起作用。测量肿瘤提取物和体液中的纤溶酶原激活剂可能提供诊断和预后信息。最后,由于纤溶酶原激活剂是一种雌二醇诱导酶,在乳腺癌中对其进行测量可能是功能性雌激素受体的一个标志物。